CV group (n=57) PV group (n=58) P value Gender F/M (n) 31/26 32/26 0.93 Age, years (means 66.13 [+ or -] 9.12 63.20 [+ or -] 8.31 0.07 [+ or -] SD) BMI, kg/[m.sup.2] 23.27 [+ or -] 2.95 22.45 [+ or -] 2.10 0.08 means [+ or -] SD) ASA I, n (%) 7 (12.28) 8 (13.79) 0.81 ASA II, n (%) 40 (70.18) 39 (67.24) 0.73 ASA III, n (%) 10 (17.54) 11 (18.97) 0.84 History of 10 (17.54) 12 (20.69) 0.67 hypertension, n (%) History of 5 (8.77%) 3 (5.17%) 0.45
cardiopathy, n (%) Smoking history, 8 (14.04%) 9 (15.52%) 0.82 n (%) PV: protective ventilation; CV: conventional ventilation; BMI: body mass index; ASA: American Society of Anesthesiologists.
Selected procedures from the Hypertension / Hypertensive
Cardiopathy care line.
Diabetic patients with NO DR, mild or moderate DR or patients where there is no co-existing systemic comorbidities like diabetic nephropathy or
cardiopathy could be taken into consideration for Multi focal IOL.
Thirty-nine patients with a clinical suspicion of DGS, VCFS, CATCH22, 22q11.2DS or a confirmed diagnosis of tetralogy of Fallot (TOF) or complex
cardiopathy were recruited in the 2012-2015 period.
This result is due to the fact that the symptoms present in neurological diseases, such as paresis, paralysis and reduced contraction of the pharynx minimize the protection of the lower airways [23], resulting in a high incidence of bronchoaspiration in patients with neuropathies, followed by diabetic and
cardiopathy patients, with statistically significant differences between them [19].
Cardiopathy patients, before and after surgery, have severe bodily limitations; fatigue and recurring lack of air prevent locomotion and handling of their own body.
PARTICIPANTS NON-PARTICIPANTS DIABETS 26.7% 20.0%
CARDIOPATHY 3.3% 7.3% CANCER 1.7% 0.0% HYPERTENSION 65.0% 43.6% ARTICULAR 10.0% 9.1% OTHERS 30.0% 20.0% Note: Table made from bar graph.
There was no significant difference between the two groups in gender ([X.sup.2]=1.705, p=0.244), age (t=0.419, p=0.678), years of education (t=1.478, p=0.146), somatopathy (Risk factors of cerebral vessels, [X.sup.2]=0.171, p=0.766; hypertension, [X.sup.2]=1.733, p=0.248;
cardiopathy, [X.sup.2]=0.865, p=0.416; diabetes, [X.sup.2]=3.179, p=0.137; hyperlipidemia, [X.sup.2]=0.865, p=0.416; stroke, [X.sup.2]=0.001, p=1, cancers, [X.sup.2]=0.979, p=1).
In terms of cardiovascular disease, type D personality has been linked to increased morbidity and mortality in ischemic heart disease (Denollet, Tekle, Pedersen, et al., 2013; Pedersen et al., 2010), an inadequate response to treatment in
cardiopathy (Denollet, Vaes, & Brutsaert, 2000), greater psychological stress, and gaining less benefit from medical treatment (Pedersen & Denollet, 2003).